Skip to main content

Celera Deal Signals First Step by Scientific Publisher to Enter Database Realm

NEW YORK, Nov. 20 — Scientific publisher John Wiley & Sons announced on Tuesday an agreement with Celera Genomics that plans to integrate Celera's bioinformatics and genomics data with journal article abstracts and full-text articles.


The partnership represents a significant step into bioinformatics for Wiley's InterScience division, which is developing a new effort to expand beyond journal publishing into database development and curation.


Under this agreement, subscribers will have direct Internet access to crosslinked information from Wiley's journals and Celera's databases. Wiley's scientific, technical, and medical division publishes Proteomics, Genetic Epidemiology, and Comparative and Functional Genomics, as well as many journals of clinical and experimental medicine.


Financial terms of the deal were not disclosed.


"What's driving this is that we have the same content base," said Patrick Kelly, vice president for business development in the scientific, medical, and technical publishing division at Wiley. "The people that are using Celera's information are also using InterScience content. I see it as a natural extension."


Kelly also said that this division of Wiley was planning additional partnerships in bioinformatics and is also looking to develop its own in-house genomics and proteomics database capability. 


"The plot is in the early stages, and we'd be partnering extensively with people who would provide resources," he said in an interview. "But at the end of the day, what we do is identify, recruit, and manage groups of people who evaluate and validate content. We're thinking of ways to leverage these groups."


The 196-year-old company, based in New York, began developing this effort about a year ago, said Kelly, and would likely be launching other similar bioinformatics partnerships within the next year.


"It has raised a few eyebrows" at Wiley, Kelly admitted. "But we're still serving the same customer base, the same user base. I see it as a natural extension of where we are."

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.